Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
GlaxoSmithKline ( (GB:GSK) ) has provided an announcement.
GSK plc has repurchased 325,000 of its ordinary shares on 13 April 2026 through BNP Paribas under its ongoing share buyback programme, paying a volume-weighted average price of 2,169.64p per share. The shares, which will be held in treasury, increase the company’s treasury stock to 258,437,615 shares, leaving 4,057,753,154 shares in issue and setting total voting rights at the same level.
Since launching this phase of the buyback on 17 February 2026, GSK has acquired 18,546,521 shares, indicating a continued focus on returning capital to shareholders and managing its capital structure. The company noted that treasury shares now account for 6.37% of voting rights, a figure investors can use in monitoring their ownership levels under U.K. disclosure and transparency rules.
The most recent analyst rating on (GB:GSK) stock is a Hold with a £22.50 price target. To see the full list of analyst forecasts on GlaxoSmithKline stock, see the GB:GSK Stock Forecast page.
Spark’s Take on GSK Stock
According to Spark, TipRanks’ AI Analyst, GSK is a Neutral.
The score is driven primarily by strong profitability and improving recent fundamentals, supported by constructive 2026 guidance and pipeline momentum. Valuation is reasonable with a modest yield, while the main constraint is technical overbought risk and ongoing balance-sheet/earnings-consistency considerations.
To see Spark’s full report on GSK stock, click here.
More about GlaxoSmithKline
GSK plc is a global biopharmaceutical company focused on developing, manufacturing and marketing vaccines, specialty medicines and general pharmaceuticals. The group targets major therapeutic areas including infectious diseases, HIV, respiratory conditions and oncology, with a broad presence across key international healthcare markets.
Average Trading Volume: 9,650,693
Technical Sentiment Signal: Buy
Current Market Cap: £86.94B
For an in-depth examination of GSK stock, go to TipRanks’ Overview page.